RA 9288 (Newborn Screening Act of 2004) Flashcards
A simple procedure to find out if a baby has a congenital disorder that may lead to mental retardation or even death if left untreated.
Newborn Screening (NBS)
Why is the newborn screening important?
- Most babies with metabolic disorders look “normal” at birth.
- By doing NBS, metabolic disorders may be detected even before clinical signs and symptoms are present.
- As a result of this, treatment can be given early to prevent consequences of untreated conditions.
Effects of organic acid disorders if is not screened:
● Developmental delay
● Breathing problems
● Neurologic damage
● Seizures
● Coma
● Early death
Effects of organic acid disorders if it is screened and managed:
● Alive
● Most will have normal development with episodes of metabolic crisis
Effects of endocrine disorder if not screened:
● Severe mental retardation
● Death
Effects of endocrine disorders if screened and managed:
● Normal
● Alive
Effects of fatty acid oxidation disorder if not screened:
● Developmental and physical delays
● Neurologic impairment
● Sudden death
● Coma
● Seizure
● Enlargement of the heart & liver
● Muscle weakness
Effects of fatty acid oxidation disorder if screened and managed:
● Usually healthy in between episodes metabolic crises
● Alive
Effects of hemoglobinopathies if not screened:
● Painful crises
● Anemia
● Stroke
● Multi-organ failure
● Death
Effects of hemoglobinopathies if screened and managed:
● Alive
● Reduces the frequency of painful crises
● May reduce the need for blood transfusions
Effects of urea cycle defect if not screened:
● Seizure
● Mental retardation
● Death
Effects of urea cycle defect if screened and managed:
● Alive
● Normal intelligence
Effect of amino acid disorders if not screened:
● Mental retardation
● Coma and death from metabolic crisis
Effects of amino acid disorders if screened and managed:
● Alive
● Normal growth
● Normal intelligence for some, learning problems to others
The Comprehensive Newborn Screening (NBS) Program was integrated as part of the country’s public health delivery system with the enactment of the Republic Act No. 9288 otherwise known as Newborn Screening Act of 2004.
NBS Program
What agency acts as the the lead agency in the implementation of the law and collaborates with other National Government Agencies (NGA) and key stakeholders to ensure early detection and management of several congenital metabolic disorders?
Department of Health (DOH)
Newborn screening program in the Philippines currently includes screening of six disorders:
- Congenital hypothyroidism (CH)
- Congenital adrenal hyperplasia (CAH)
- Phenylketonuria (PKU)
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency
- Galactosemia (GAL)
- Maple syrup urine disease (MSUD)
When should the newborn screening usually done?
After 24 hours from birth
How is the newborn screening done?
A few drops of blood are taken from the baby’s heel, blotted on a special absorbent filter card, and then sent to Newborn Screening Center (NSC).
Who will collect the sample?
● Physician (4)
● Nurse (2)
● Medical technologist (1)
● Trained midwife (3)
National Policy and Strategic Framework on Expanded Newborn Screening for 2017-2030
Administrative Order No. 2018-0025
The Guidelines on the Implementation of the Expanded Newborn Screening Program
Administrative Order No. 2014-0045
Enumerate the six operational NSCs in the country:
- NIH at the University of the Philippines Manila Confirmatory tests are done at newborn screening reference centers (UPM NIH).
- Visayas - West Visayas State University Medical Center, Iloilo City
- Mindanao - Southern Philippines Medical Center, Davao City
- Central Luzon - Angeles University Foundation Medical Center
- Southern Luzon - Mariano Marcos Memorial Hospital and Medical Center, Tanauan City, Batangas
- Northern Luzon - Daniel Mercado Medical Center, Batac City, Ilocos Norte
What is the Section 1 of RA 9288?
Title: “Newborn Screening Act of 2004”